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Women with ovarian cancer typically experience symptoms 
before diagnosis; such symptoms for other gynecologic can-
cers have not been systematically studied. We investigated 
which symptoms of gynecologic cancers prompt intention 
to seek care among women and whether demographic dif-
ferences in intention exist. This study was undertaken, 
in part, to inform development of the Centers for Disease 
Control  and  Prevention’s  campaign,  Inside  Knowledge: 
Get the Facts About Gynecologic Cancer.
Methods
We  analyzed  the  2008  HealthStyles  dataset  (n  =  2,991 
women), an annual, cross-sectional, national mail survey. 
We calculated weighted percentages of women who indi-
cated an intention to seek care for symptoms (defined as 
intention to call or see a doctor) by demographic character-
istics and level of concern about developing a gynecologic 
cancer. We evaluated independent predictors of intention 
to seek care for each symptom.
Results
or  most  symptoms,  more  than  50%  of  women  reported 
an intention to seek care. Greater percentages of women 
indicated an intention to seek care for symptoms clearly 
gynecologic (eg, 91%, postmenopausal bleeding) than for 
symptoms  not  clearly  gynecologic  (eg,  37%,  feeling  full 
after eating a small amount). For most symptoms, after 
adjustment, black women, postmenopausal women, and 
women with greater concern about developing gynecologic 
cancers were more likely than their counterparts to intend 
to seek care.
Conclusion
Intention to seek care differed by race, menopausal status, 
and level of concern about developing a gynecologic cancer. 
These findings will help in developing messages to educate 
women about the array of gynecologic and nongynecologic 
cancer symptoms.
Introduction
Gynecologic  cancers  (cervical,  ovarian,  uterine,  vaginal, 
and vulvar) are diagnosed in approximately 80,000 women 
per year (1); with the exception of cervical cancer, no screen-
ing tests are available to decrease morbidity or mortality 
from these cancers. Promoting awareness of gynecologic 
cancer symptoms may be a strategy for earlier detection of 
at least some gynecologic cancers (2). Symptoms noted by 
patients before diagnosis of gynecologic cancers have not 
been  well  studied.  Most  research  on  gynecologic  cancer 
symptoms  has  focused  on  ovarian  cancer.  Women  with 
ovarian cancer typically experience some symptoms before 
diagnosis, and they experience them more frequently than 
women without cancer, but symptoms are often nonspecific 
and are also present in many women without cancer (3-6). 
Common symptoms of ovarian cancer include abdominal 
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distention, bloating, and unusual abdominal pain (3-12), 
each of which may not be immediately recognizable as a 
symptom of ovarian or other gynecologic cancers (13).
Gynecologic  cancers  have  diverse  symptoms.  Symptoms 
specific to each of the 5 main types of gynecologic cancers 
may include, but are not limited to, the following:
• Cervical cancer: unusual vaginal bleeding (eg, irregular 
periods,  bleeding  after  sexual  intercourse)  or  vaginal 
discharge (14,15).
• Ovarian  cancer:  having  pelvic  or  abdominal  pain  or 
pressure, back pain, or bloating; having to urinate more 
frequently  or  urgently  than  usual;  feeling  full  after 
eating a small amount of food; having unusual vaginal 
discharge;  and  postmenopausal  vaginal  bleeding  (3-
6,8,10,12-14,16,17).
• Uterine cancer: postmenopausal vaginal bleeding, bleed-
ing between periods, periods that are either longer or 
heavier  than  normal,  and  pelvic  or  abdominal  pain 
(14,18).
• Vaginal cancer: having unusual vaginal bleeding, espe-
cially after sexual intercourse, or having to urinate more 
frequently or urgently than usual (14,19).
• Vulvar cancer: persistent itching of the vulva, changes 
in the color of the vulva, so that it looks redder or whiter 
than usual; rash- or wart-like skin changes in the vulva; 
and a persistent sore on the vulva (14,20).
These symptoms may also be linked to various health con-
ditions unrelated to gynecologic cancers (3-6).
The Centers for Disease Control and Prevention (CDC), in 
collaboration with the Department of Health and Human 
Services’ Office on Women’s Health, established the Inside 
Knowledge: Get the Facts About Gynecologic Cancer cam-
paign  to  support  the  Gynecologic  Cancer  Education  and 
Awareness Act of 2005, or Johanna’s Law, which was signed 
into law on January 12, 2007 (www.cdc.gov/cancer/gyneco-
logic/pdf/JohannasLaw.pdf). The campaign is charged with 
educating women and health care providers about the signs 
and  symptoms,  screening  tests  (if  available),  prevention 
strategies, and risk factors associated with the 5 main types 
of gynecologic cancer. Furthermore, the campaign encour-
ages women to pay attention to what is normal for them, so 
they may recognize any persistent changes and seek care in 
an appropriate and timely manner.
Data on women’s intentions to seek care are needed to help 
shape  education  and  awareness  messages  of  the  Inside 
Knowledge campaign and to provide a baseline evaluation 
of existing campaign messages. The objective of this study 
was to investigate symptoms of gynecologic cancers that 
prompt intention to seek care among women and whether 
demographic differences in intention to seek care exist.
Methods
We  used  secondary  data  from  the  2008  HealthStyles 
survey,  to  examine  the  relationship  between  intention 
to  seek  care  and  demographic  characteristics.  Analyses 
of  HealthStyles,  a  de-identified  dataset,  were  declared 
exempt by CDC’s institutional review board.
Study design and sample population
HealthStyles is an annual, cross-sectional, national mail 
survey  of  adults  aged  18  years  or  older  conducted  by 
Porter Novelli, a global public relations agency. The sur-
vey includes questions about health beliefs, attitudes, and 
behaviors and is mailed to people enrolled in the Synovate 
Global Opinions Panel (21). Porter Novelli develops the 
survey annually on the basis of current health topics and 
recommendations  from  public  health  agencies.  Results 
from HealthStyles data items are similar to results from 
the Behavioral Risk Factor Surveillance System (22). In 
2008, CDC’s Division of Cancer Prevention and Control 
licensed items from HealthStyles. The 2008 HealthStyles 
survey  was  mailed  to  7,000  of  10,108  people  who  had 
returned an earlier related survey, ConsumerStyles; peo-
ple  were  selected  to  participate  in  the  earlier  survey 
through stratified random sampling to create a nationally 
representative  sample.  Participants  in  ConsumerStyles 
receive small incentives for participation (a 30-min tele-
phone calling card or a lottery entry to win between $50 
and $1,000). We used a supplement to ensure adequate 
representation  of  low-income  and  racial/ethnic  minor-
ity groups. HealthStyles surveys were returned by 5,399 
participants (77.1%[5,399 of 7,000]). We poststratified and 
weighted the data according to the US Census distribu-
tion of age, race/ethnicity, sex, household size, and annual 
household income.
Outcome measures
Only women (n = 2,991) answered questions on gynecologic 
cancers and intention to seek care. We assessed intention 
through 2 sets of questions. The first set, comprising 10 
questions, each referring to 1 symptom, asked women how VOLUME 8: NO. 6
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they would respond to each symptom (“If you had any of the 
following, would you call or see a doctor?”). Nine of these 
symptoms are typically considered gynecologic (ie, clearly 
related to the reproductive system). Throughout this arti-
cle, we refer to these 9 symptoms as “abnormal,” although 
the survey questions did not refer to them as such. In this 
set of questions, we also included a question on intention 
to seek care for influenza-like symptoms (developed and 
included before the outbreak of H1N1), which are not typi-
cally associated with gynecologic cancers, as a control. The 
second set, comprising 5 questions, assessed intention to 
seek care for 5 chronic symptoms. The survey asked, “If 
it was not normal for you, and you experienced any of the 
following every day for 2 weeks or longer, would you call or 
see a doctor?” These 5 symptoms are typically considered 
nongynecologic (ie, not obviously related to the reproductive 
system). Throughout this article, we refer to these 5 symp-
toms as “abnormal and persistent” symptoms, although the 
survey did not refer to them as such. Response options for 
both sets of questions on intention to seek care were yes, 
no, or “not sure” for each symptom.
The  survey  also  asked  participants  about  their  concern 
about developing each of the 5 gynecologic cancers; partici-
pants were asked to express concern on a scale of 1 (not at 
all concerned) to 4 (very concerned).
The  survey  collected  data  on  age,  annual  household 
income,  education,  employment  status,  marital  status, 
menopausal  status,  race/ethnicity,  tobacco  use,  alcohol 
use, having a mammogram, and having a Papanicolaou 
(Pap) test. We defined menopausal status on the basis of 
the question, “Have you gone through menopause (end of 
menstruation)?” Possible responses to this question were 
yes, no, “I’m going through it now,” and not sure.
Statistical analyses
Our  analyses  were  mostly  descriptive;  we  tested  no 
hypotheses. We calculated intention to seek care as the 
weighted percentage of women, for each symptom, who 
answered yes to the question on whether they would call 
or see a doctor. We calculated weighted percentages for 
demographic characteristics and concern about develop-
ing a gynecologic cancer. We established subcategories for 
each covariate. We categorized menopausal status into 3 
groups: postmenopausal was established by the response 
“Yes, I’ve gone through menopause,” perimenopausal by 
the response “I’m going through menopause now,” and pre-
menopausal by the response “No, I haven’t gone through 
menopause.” We calculated mean gynecologic cancer con-
cern (mean concern, 2.4) by averaging the scores for each 
of the 5 cancers.
We performed separate analyses for each of the 15 symp-
toms.  We  entered  each  covariate  (eg,  age)  into  its  own 
unadjusted logistic regression model; the outcome of inter-
est was intention to seek care for each symptom. If the 
covariate was found to be significantly associated (P < .05) 
with intention to seek care for a majority of the symptoms, 
we included it in the full model for each symptom. The 
full model also included reported intention to seek care for 
influenza-like symptoms to control for level of generalized 
health care use and concern. The full model for abnormal 
symptoms differed from the full model for abnormal and 
persistent symptoms. From the adjusted models, we esti-
mated  a  weighted  predicted  probability  (expressed  as  a 
percentage) of intention to seek care for each covariate by 
setting the remainder of the covariates to their reference 
level. The predicted probability of intention to seek care for 
each referent group is therefore equivalent. We calculated 
weighted, adjusted percentages, rather than odds ratios, 
because we were more interested in estimating absolute 
levels  of  intention  to  seek  care  than  relative  levels.  We 
excluded women with missing data on a variable from any 
analysis of that variable. We used SAS software, version 9.2 
(SAS Institute, Inc, Cary, North Carolina) for all analyses. 
We did not use higher-order statistics (eg, tests for interac-
tion) because our analysis did not test a hypothesis.
Results
Most survey participants were white (65%), aged 45 years 
or older (65%), married (61%), had at least some college 
education (66%), and had an annual household income of 
$40,000 or more (54%). Overall, more than 50% of women 
reported an intention to seek care for most of the 15 symp-
toms (Table 1); only 41.0% reported intention to seek care 
for  bloating  and  only  37.2%  for  feeling  full  after  eating 
a small amount of food. A greater percentage of women 
reported an intention to seek care for gynecologic symp-
toms (eg, postmenopausal vaginal bleeding, 90.5%; vaginal 
itching, 90.4%; vaginal discharge, 83.1%) than for nongy-
necologic symptoms (eg, bloating, feeling full after eating 
a small amount of food). The exception to this finding was 
that, among premenopausal women, only 54.9% intended 
to  seek  care  for  periods  that  lasted  longer  than  7  days 
and only 57.6% intended to seek care for vaginal bleeding 
between periods, both of which are gynecologic symptoms.VOLUME 8: NO. 6
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In unadjusted analyses of abnormal symptoms, younger 
women (aged 18-34 y) were less likely than older women 
(aged ≥50 y), and premenopausal women were less likely 
than postmenopausal women, to report intention to seek 
care.  Black  women  (and  to  a  lesser  degree,  Hispanic 
women) were more likely than white women, and women 
with greater concern about developing a gynecologic can-
cer (≥2.4) were more likely than women with less concern 
(<2.4), to report intention to seek care for abnormal symp-
toms. We found no consistent differences in intentions to 
seek care for abnormal symptoms by annual household 
income, education, employment status, or marital status.
In unadjusted analyses of abnormal and persistent symp-
toms, younger women were less likely than older women, 
premenopausal  women  were  less  likely  than  postmeno-
pausal  women,  and  women  with  middle-level  incomes 
($25,000-$59,999)  were  less  likely  than  women  in  the 
highest level of income (≥$60,000), to report intention to 
seek  care.  We  found  no  consistent  differences  in  inten-
tions for abnormal and persistent symptoms by education, 
employment status, marital status, race/ethnicity, or con-
cern about developing a gynecologic cancer.
Results were largely unchanged after adjustment, except 
the effect of age, which became statistically nonsignificant 
for many symptoms. After adjustment, black and Hispanic 
women (compared with white women), women who report-
ed  they  would  seek  care  for  influenza-like  symptoms 
(compared with women who would not), postmenopausal 
women  (compared  with  premenopausal  women),  and 
women  with  greater  concern  about  gynecologic  cancer 
(compared with women less concerned) were more likely to 
report they would seek care for abnormal symptoms (Table 
2). For abnormal and persistent symptoms, women with 
annual incomes of $60,000 or more, women who reported 
they  would  seek  care  for  influenza-like  symptoms,  and 
postmenopausal women were more likely to report inten-
tion to seek care than their counterparts, after adjustment 
(Table 3). We found none of the following health-related 
behaviors to be a confounder: tobacco use, alcohol use, hav-
ing a mammogram, or having a Pap test.
Discussion
Women’s  intention  to  seek  care  differed  by  age  and 
demographic  characteristics.  Postmenopausal  women, 
black  women,  women  more  concerned  about  developing 
a gynecologic cancer, and women with annual incomes of 
$60,000 or more were more likely than their counterparts 
to report they would seek care for most symptoms. Why 
black women, and to a lesser degree, Hispanic women, are 
more likely to report intention to seek care for abnormal 
symptoms is not entirely understood and deserves further 
study. Women were generally more likely to report inten-
tion to seek care for gynecologic symptoms than nongyne-
cologic symptoms; the exceptions were for premenopausal 
women, who reported low levels of intention to seek care 
(55% and 58%) for 2 gynecologic symptoms. These data 
suggest a need to educate women about the array of gyne-
cologic cancer signs, symptoms, and risk factors, a fun-
damental aim of CDC’s Inside Knowledge campaign and 
other public health initiatives.
Although  we  do  not  have  data  on  reasons  for  women’s 
intentions to seek care for certain symptoms, a possible 
interpretation is that women experience some gynecologic 
symptoms relatively infrequently, and thus, they consider 
them to be more serious than nongynecologic symptoms 
(eg, gastrointestinal symptoms). One study showed that 
gastrointestinal symptoms were not recognized as serious 
by women (23) despite their presence before a diagnosis of 
ovarian cancer (3-6,8-12). This lack of recognition is poten-
tially problematic; in 1 study, women who visited a physi-
cian and presented with gastrointestinal symptoms were 
more likely to be diagnosed with late-stage ovarian cancer 
and  received  surgical  evaluation  less  frequently  than 
women who presented with gynecologic symptoms (12).
Whether  earlier  recognition  of  symptoms  will  translate 
into earlier detection and improved outcomes for women 
with gynecologic cancers is unknown. The predictive value 
of symptoms for early detection of ovarian cancer has been 
estimated to be low, and therefore it may have limited 
clinical use (24).
Although  studies  have  estimated  women’s  recognition 
of ovarian cancer symptoms at 26% to 47% (13), we did 
not assess whether participants associated the symptoms 
included in our study with gynecologic cancer. Women in 
our study were asked to describe their intention to seek 
care related to symptoms that they may or may not have 
recognized as being associated with gynecologic cancers. 
Our focus on care seeking was not intended to reflect wom-
en’s knowledge about symptoms’ link to ovarian or other 
gynecologic  cancers  but  instead  identifies  gynecologic 
cancer symptoms that are most likely to prompt respon-
dents to seek health care. This focus is consistent with 
the Theory of Planned Behavior (25) in which behavioral VOLUME 8: NO. 6
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intentions, or a person’s perceived likelihood of performing 
a certain behavior, have been found to be a strong predic-
tor of actual behavior.
This study has limitations. We asked about intentions to 
seek care, which may not be equivalent to actual care-
seeking behavior. Because our data are self-reported (and 
subject to response bias, including social desirability bias) 
and  reflect  only  intention  to  seek  care,  they  may  over 
estimate  actual  care-seeking  behavior.  Our  survey  was 
not population based, although it was weighted to be rep-
resentative of the US population. Also, data on additional 
possible confounders, such access to medical care, health 
insurance,  and  additional  psychosocial  constructs  (eg, 
risk perception, worry) were not available. However, the 
survey had a high response rate and a large sample size, 
enabling us to consider many characteristics potentially 
associated with intention to seek care.
Future studies should explore why women choose to seek 
care  for  certain  symptoms  (eg,  do  they  consider  some 
symptoms more worrisome than others?) and investigate 
other factors that may influence actual care seeking. The 
identification  of  diseases  or  conditions  women  associate 
with these symptoms would help in the design of educa-
tional materials and intervention efforts.
To  our  knowledge,  this  is  one  of  only  a  few  studies  to 
investigate  ovarian  cancer  symptoms  that  prompt  an 
intention to seek care among US women and the first to 
investigate  symptoms  of  other  gynecologic  cancers.  The 
results of our study add to the growing body of literature 
on  whether  certain  symptoms  prompt  an  intention  to 
seek care among certain groups of women. CDC’s Inside 
Knowledge campaign and other public health initiatives 
should develop communication and education strategies to 
increase awareness of gynecologic cancer symptoms, with 
a focus on symptoms that may manifest as nongynecologic 
problems. Efforts should encourage appropriate care seek-
ing among all groups of women but pay particular atten-
tion to women who may be less likely to seek care, such as 
white women, premenopausal women, and women with 
low incomes.
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Tables




Yes No Not Sure
Abnormal, predominately gynecologica
Rash or sore on your genitals that does not go away 91.8 .6 2.6
Vaginal bleeding after you have gone through menopause (postmenopausal women only) 90. 6. .2
Vaginal itching that does not get better with over-the-counter treatments/creams 90.4 . .8
Vaginal discharge that is not normal for you 8.1 10. 6.2
Skin on your genitals becoming redder or whiter than is normal for you 82.1 9.1 8.9
Vaginal bleeding (not related to your period) after sex on 2 or more occasions .1 1.4 9.6
Pelvic or abdominal pain after sex 6.2 20. 16.
Influenza-like symptoms (eg, fever and body aches) for more than  daysb 62. 2.2 12.1
Vaginal bleeding between periods (premenopausal women only) .6 2.1 10.
Period that lasts more than  days (premenopausal women only) 4.9 0.9 14.2
Abnormal and persistent, predominately nongynecologicc
Pelvic or abdominal pain 88.9 6.4 4.
Urinating more often or more urgently than usual 2. 18.0 9.4
Back pain 9.0 2.6 1.4
Bloating 41.0 40. 18.
Feeling full after eating a small amount of food .2 41. 21.
 
a Survey participants were asked, “If you had any of the following, would you call or see a doctor?” Except for the question on influenza-like symptoms, these 
symptoms are typically considered gynecologic (ie, clearly related to the reproductive system) and are referred to as abnormal in this table (but were not during 
the survey). 
b We included a question on intention to seek care for influenza-like symptoms, which are not typically associated with gynecologic cancers, as a control. 
c Survey participants were asked, “If it was not normal for you and you experienced any of the following every day for 2 weeks or longer, would you call or see 
a doctor?” These symptoms are typically considered nongynecologic (ie, not obviously related to the reproductive system) and are referred to as abnormal and 
persistent in this table (but not during the survey).VOLUME 8: NO. 6
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Table 2. Model-Adjusted Predicted Probabilities (%) of Intention to Seek Care for Abnormal, Predominately Gynecologic Symptoms, 
































18-4 8. NC . .9f 8.2 .4 24. 40.1 2.
-49 80.9 60.6f 9. 61.f 8. . 1.4 9. .
≥50 
(Reference)
80.9 81.9 .2 4.4 61. 60. 1. 42. .6
Race
Black 84.0 9. 8.f 84.f 80.8f 6.f 48.f 68.f 0.2f
Hispanic 8.8 82.2 8.2 80.f 2.f 6.2 1.6 1.9f 40.f
Other 69.f 89.1 66.8f 8.6 8.0 64.8 .0 41.1 28.
White 
(Reference)
80.9 81.9 .2 4.4 61. 60. 1. 42. .6
Would seek care for influenza-like symptoms
Yes 96.f 9.9f 92.f 90.9f 86.f 9.f 6.1f 4.f .f
No/not sure 
(Reference)
80.9 81.9 .2 4.4 61. 60. 1. 42. .6
Menopausal status
Post 8.4 NA 8. 9.0 6.9 68.9f 41.6f NA NA
Peri 8.8 NA 8.9 .9 68.1 0.1f 42.2f NA NA
Pre 
(Reference)
80.9 NA .2 4.4 61. 60. 1. NA NA
Concern about developing a gynecologic cancere
<Mean 
(Reference)
80.9 81.9 .2 4.4 61. 60. 1. 42. .6
≥Mean 8.8 88.8f 81. 8.2 0.0f 68.6f 4.f 0.0f 40.f
 
Abbreviations: NC, not calculated; NA, not applicable. 
a Predicted probabilities are estimated from a logistic regression model including all variables listed in the table and are calculated by setting all the other vari-
ables to their reference level. Survey participants were asked, “If you had any of the following, would you call or see a doctor?” These symptoms are typically 
considered gynecologic (ie, clearly related to the reproductive system) and are referred to as abnormal in this table (but were not during the survey). 
b Postmenopausal women only. 
c On 2 or more occasions. 
d Premenopausal women only. 
e Participants responded on a scale from 1 (not at all concerned) to 4 (very concerned); the mean score was 2.4. 
f Significantly different from reference group (P < .0).VOLUME 8: NO. 6
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Table 3. Model-Adjusted Predicted Probabilities (%) of Intention to Seek Care for Abnormal and Persistent, Predominately 
Nongynecologic Symptoms, by Demographic Characteristics, Among Women (n = 2,991), HealthStyles Survey, 2008 a
Pelvic or Abdominal 
pain
Having to Urinate 
More Often Back Pain Bloating
Feeling Full After 
Eating a Small Amount
Age
18-4 8.0b 61. 8.b 24. 18.6
-49 82.1b .9 4. 2.2 22.2
≥50 (Reference) . 60.4 49. 2.8 20.9
Annual income, $
<2,000 9.b . 4.2 21.9 19.4
2,000-9,999 64.1b 2.0b 4.0b 16.9b 1.2b
40,000-9,999 6.9 .0 4. 19.9 1.9
≥60,000 (Reference) . 60.4 49. 2.8 20.9
Would seek care for influenza-like symptoms
Yes 91.2b 8.9b .1b 48.b 4.6b
No/not sure 
(Reference)
. 60.4 49. 2.8 20.9
Menopausal status
Post 8.9b 2.b 46.1 4.2b 2.8b
Peri 8.0b 6. 46.8 29.9 26.6
Pre (Reference) . 60.4 49. 2.8 20.9
 
a Predicted probabilities are estimated from a logistic regression model including all variables listed in the table and are calculated by setting all the other vari-
ables to their reference level. Survey participants were asked, “If it was not normal for you, and you experienced any of the following every day for 2 weeks or 
longer, would you call or see a doctor?” These symptoms are typically considered nongynecologic (ie, not obviously related to the reproductive system) and are 
referred to as abnormal and persistent in this table (but were not during the survey). 
b Significantly different from reference group (P < .0).